BChE-IN-14

Names

[ Name ]:
BChE-IN-14

Biological Activity

[Description]:

BChE-IN-14 (compound 19c) is a selective butyrylcholinesterase (BChE) inhibitor with IC50s of 0.23 and 0.011 μM for eqBChE and hBChE, respectively. BChE-IN-14 shows good blood brain barrier permeation and primary cell safety. BChE-IN-14 is able to restore cognitive impairment in vivo, it can be used for the research of Alzheimer’s disease[1].

[Related Catalog]:

Signaling Pathways >> Others >> Others

Research Areas >> Neurological Disease

[Target]

IC50: 0.23 μM (eqBChE), 0.011 μM (hBChE)[1]

[In Vitro]

BChE-IN-14 (0.0001-100 μM) inhibits eqBChE from house serum and hBChE with IC50s of 0.23 and 0.011 μM, respectively[1].

[In Vivo]

BChE-IN-14 (15 mg/kg; p.o. for Aβ1-42 injection days 3-8) affects memory and cognitive function in AD mice model[1]. Animal Model: ICR mice with oligomerized Aβ1-42 peptide injection[1] Dosage: 15 mg/kg Administration: Oral gavage; 15 mg/kg for Aβ1-42 injection days 3-8 Result: Improved memory and cognitive function in vivo and showed a shorter latency than donepezil.

[References]

[1]. Lu X, et al. Design, synthesis, and biological evaluation of aromatic tertiary amine derivatives as selective butyrylcholinesterase inhibitors for the treatment of Alzheimer's disease. Eur J Med Chem. 2022 Sep 2;243:114729.

Chemical & Physical Properties

[ Molecular Formula ]:
C₂₄H₂₉N

[ Molecular Weight ]:
331.49

Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.